Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New Developments
Cytotoxic drugs, which are commonly used for the pharmacotherapy of many forms of cancer, often cause substantial toxicity to the patient without being able to induce long-lasting remissions. Ligands specific to accessible tumor-associated targets, capable of selective localization at the...
Main Authors: | Samuele Cazzamalli, Alberto Dal Corso, Dario Neri |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2017-10-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://www.chimia.ch/chimia/article/view/1667 |
Similar Items
-
Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
by: Adina Borbély, et al.
Published: (2019-04-01) -
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
by: Mo Wu, et al.
Published: (2022-11-01) -
Co-Opting Host Receptors for Targeted Delivery of Bioconjugates—From Drugs to Bugs
by: Kristen M. Tummillo, et al.
Published: (2021-03-01) -
Recent progress of aptamer‒drug conjugates in cancer therapy
by: Jiaxuan He, et al.
Published: (2023-04-01) -
Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
by: Shota Oyama, et al.
Published: (2021-08-01)